These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Pulmonary embolism thrombolysis: a clarion call for international collaboration. Goldhaber SZ J Am Coll Cardiol; 1992 Feb; 19(2):246-7. PubMed ID: 1732348 [No Abstract] [Full Text] [Related]
9. When urokinase was gone: commentary on another year of thrombolysis without urokinase. Gates J; Hartnell GG J Vasc Interv Radiol; 2004 Jan; 15(1 Pt 1):1-5. PubMed ID: 14709680 [No Abstract] [Full Text] [Related]
10. Life-threatening pulmonary embolism with right-sided heart thrombus. Rapid recovery with recombinant tissue plasminogen activator. d'Ivernois C; Le Metayer P; Fischer B; Haissaguerre M; Warin JF Chest; 1994 Apr; 105(4):1291-2. PubMed ID: 8162778 [TBL] [Abstract][Full Text] [Related]
11. Impaired resolution of massive pulmonary embolism associated with an inhibited fibrinolytic response. Deitcher SR; Lucore CL; Eisenberg PR Am J Med; 1994 May; 96(5):483-4. PubMed ID: 8192182 [No Abstract] [Full Text] [Related]
12. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated? Dalen JE; Alpert JS; Hirsh J Arch Intern Med; 1997 Dec 8-22; 157(22):2550-6. PubMed ID: 9531222 [No Abstract] [Full Text] [Related]
13. Thrombolytic effects of tissue-type and urokinase-type plasminogen activators in rabbits with experimental pulmonary thromboembolization. Rahman F Fukuoka Igaku Zasshi; 1990 Sep; 81(9):303-12. PubMed ID: 2125971 [TBL] [Abstract][Full Text] [Related]